Impact of Thrombolysis, Intra-aortic Balloon Pump Counterpulsation, and Their Combination in Cardiogenic Shock Complicating Acute Myocardial Infarction: A Report from the SHOCK Trial Registry
نویسندگان
چکیده
Timothy A. Sanborn, MD, FACC,* Lynn A. Sleeper, SCD,† Eric R. Bates, MD, FACC,‡ Alice K. Jacobs, MD, FACC,§ Jean Boland, MD,\ John K. French, MBCHB, PHD,¶ Jo Dens, MD,# Vladimir Dzavik, MD,** Sebastian T. Palmeri, MD, FACC,†† John G. Webb, MD, FACC,‡‡ Mark Goldberger, MD, FACC,§§ Judith S. Hochman, MD, FACC,\\ for the SHOCK Investigators New York, New York; Watertown, Massachusetts; Ann Arbor, Michigan; Boston, Massachusetts; Liège and Leuven, Belgium; Auckland, New Zealand; Alberta and Vancouver, Canada; New Brunswick, New Jersey; Bronx, New York
منابع مشابه
Does intra-aortic balloon support for myocardial infarction with cardiogenic shock improve outcome?
CITATION Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Böhm M, Ebelt H, Schneider S, Schuler G, Werdan K; IABP-SHOCK II Trial Investigators: Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012, 367:1287-1296. BACKGROUND In the current inte...
متن کاملSystematic review: Intra-aortic balloon counterpulsation pump therapy: a critical appraisal of the evidence for patients with acute myocardial infarction
Introduction Intra-aortic balloon counterpulsation pump (IABP) therapy has been used in several clinical situations, predominantly in critically ill patients, since 1968 [1]. In acute myocardial infarction (AMI) patients who are experiencing continued ischemia, IABP therapy may be used in an attempt to improve patency of an infarct-related coronary artery (IRA) and reduce the rates of recurrent...
متن کاملIntra-Aortic Balloon Pump Counterpulsation during Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction and Cardiogenic Shock: Insights from the British Columbia Cardiac Registry
BACKGROUND Cardiogenic shock complicating ST-elevation myocardial infarction (STEMI) is associated with significant morbidity and mortality. In the primary percutaneous coronary intervention (PPCI) era, randomized trials have not shown a survival benefit with intra-aortic balloon pump (IABP) therapy. This differs to observational data which show a detrimental effect, potentially reflecting bias...
متن کاملIntra-aortic balloon pump in patients with cardiogenic shock complicating myocardial infarction: a systematic review and meta-analysis of randomized trials (protocol)
BACKGROUND Cardiogenic shock is the leading cause of death in patients with acute myocardial infarction. Despite significant advancements in health technology and research, hospital mortality approaches 50%. The intra-aortic balloon pump is a mechanical hemodynamic assist device that has been used for over 40 years in the management of patients with cardiogenic shock. A recent randomized trial ...
متن کامل[Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry].
OBJECTIVES This SHOCK Study report seeks to provide an overview of patients with cardiogenic shock (CS) complicating acute myocardial infarction (MI) and the outcome with various treatments. The outcome of patients undergoing revascularization in the SHOCK Trial Registry and SHOCK Trial are compared. BACKGROUND Cardiogenic shock is the leading cause of death in patients hospitalized for acute M...
متن کامل